Skip to main content

Assessment of ARIA Sufficiency: Leqembi (lecanemab-irmb)

    Basic Details
    Approval Date
    Thursday, July 6, 2023
    Original Posting Date
    Health Outcome(s)
    amyloid related imaging abnormality-edema (ARIA-E)
    amyloid related imaging abnormality-hemosiderin deposition (ARIA-H)
    intracerebral hemorrhage (ICH)